MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
132.41%
Quick Ratio
132.41%
Cash Ratio
112.79%
Debt to Asset Ratio
48.55%
Unit: Thousand (K) dollars
Assets Breakdown
    • Total non-current assets
    • Total current assets
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities cur...
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
2,398 3,999 5,435 6,525
Restricted cash security deposit
50 50 50 50
Prepaid expenses and other current assets
367 26 168 693
Total current assets
2,815 4,075 5,653 7,268
Leasehold improvements and equipment net
138 138 156 158
Assets held for sale - net
NaN NaN 70 70
Operating lease right-of-use assets net
457 531 1,351 1,462
Finance lease right-of-use assets net
4 4 5 6
In-process research and development
2,260 2,260 2,260 2,260
Restricted cash security deposit
200 200 200 200
Total non-current assets
3,059 3,133 4,042 4,156
Total assets
5,874 7,208 9,695 11,424
Accounts payable
712 315 80 167
Accrued expenses
694 452 564 795
Operating lease liabilities current
718 694 846 817
Financing lease liabilities current
2 2 5 5
Total current liabilities
2,126 1,463 1,495 1,784
Deferred tax liability
257 257 257 257
Operating lease liabilities net of current portion
464 653 1,472 1,697
Financing lease liabilities net of current portion
5 5 11 11
Total non-current liabilities
726 915 1,740 1,965
Total liabilities
2,852 2,378 3,235 3,749
Common stock par value 0.0001 per share, 500,000,000 shares authorized at march 31, 2026 and december 31, 2025 6,406,191 issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
1 1 1 1
Additional paid-in capital
215,729 215,616 215,334 214,399
Accumulated deficit
-212,708 -210,787 -208,875 -206,725
Total stockholders equity
3,022 4,830 6,460 7,675
Total liabilities and stockholders equity
5,874 7,208 9,695 11,424
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

In-process research anddevelopment$2,260K Operating leaseright-of-use assets net$457K Restricted cash securitydeposit$200K Leasehold improvementsand equipment net$138K Finance leaseright-of-use assets net$4K Cash and cashequivalents$2,398K Prepaid expenses andother current assets$367K Restricted cash securitydeposit$50K Total non-currentassets$3,059K Total current assets$2,815K Total assets$5,874K Total liabilities andstockholders equity$5,874K Total stockholdersequity$3,022K Total liabilities$2,852K Accumulated deficit-$212,708K Additional paid-in capital$215,729K Total currentliabilities$2,126K Total non-currentliabilities$726K Common stock par value0.0001 per share,...$1K Operating leaseliabilities current$718K Accounts payable$712K Accrued expenses$694K Financing leaseliabilities current$2K Operating leaseliabilities net of current...$464K Deferred tax liability$257K Financing leaseliabilities net of current...$5K

Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma Holdings, Inc. (MTNB)